Cantitate/Preț
Produs

From Obesity to Diabetes: Handbook of Experimental Pharmacology, cartea 274

Editat de Juergen Eckel, Karine Clément
en Limba Engleză Hardback – 22 iul 2022
Obesity is a major risk factor for the development of type 2 diabetes and its associated complications, a major socio-economic burden for health care systems. The worldwide prevalence of obesity doubled since 1980 and as a consequence the number of patients with diabetes has been continuously rising with more than 450 Mio. people suffering from this disease at the present time. Substantial progress has been made in understanding the molecular pathways leading from excessive fat accumulation to metabolic perturbation and finally diabetes manifestation. This edition of the "Handbook of Experimental Pharmacology" aims to analyze new insight into the pathophysiology of obesity, to decipher the complex links to diabetes and its complications, and to collect most recent information on new strategies for prevention and treatment of obesity and diabetes.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 100290 lei  38-44 zile
  Springer International Publishing – 22 iul 2023 100290 lei  38-44 zile
Hardback (1) 102514 lei  38-44 zile
  Springer International Publishing – 22 iul 2022 102514 lei  38-44 zile

Din seria Handbook of Experimental Pharmacology

Preț: 102514 lei

Preț vechi: 107910 lei
-5% Nou

Puncte Express: 1538

Preț estimativ în valută:
19619 20748$ 16365£

Carte tipărită la comandă

Livrare economică 25-31 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030999940
ISBN-10: 3030999947
Pagini: 513
Ilustrații: VIII, 513 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 1.02 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

Part I Obesity. Epidemiology of Obesity.- The Circadian Clock and Obesity.- Nutrition and Microbiome.- From Obesity to Diabetes: The Role of the Adipose Organ.- Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy.- The Enteroendocrine System in Obesity.- Insights from Studies of White Adipose Tissue Using Single-Cell Approaches.- Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction.- Obesity, Senescence, and Senolytics.- Obesity and Obstructive Sleep Apnea.- Part II Diabetes and Complications. Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance.- Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.- NAFLD and NASH: The Metabolically Diseased Liver.- Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.- Diabetic Peripheral Neuropathy.- Part III Lifestyle Modifications and Future Treatments. Weight Loss Strategies.- PhysicalActivity, Obesity and Weight Loss Maintenance.- Bariatric/Metabolic Surgery.- Drugs for Treating Obesity.- Novel Drugs for Diabetes Therapy.- Novel Approaches to Restore Pancreatic Beta-Cell Mass
and Function.- Precision Medicine and Obesity.- Targeting the Enteroendocrine System for Treatment of Obesity.

Caracteristici

Provides new insights into the pathophysiology of obesity Deciphers the complex links to diabetes and its complications Collects most recent information on new strategies for prevention and treatment of obesity and diabetes